ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 183 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $987,000 | +19.1% | 23,445 | +1.9% | 0.01% | 0.0% |
Q3 2019 | $829,000 | +146.0% | 23,018 | +83.3% | 0.01% | +200.0% |
Q2 2019 | $337,000 | -9.4% | 12,558 | -9.0% | 0.00% | -33.3% |
Q1 2019 | $372,000 | +65.3% | 13,807 | +5.4% | 0.00% | +50.0% |
Q4 2018 | $225,000 | -19.4% | 13,099 | -2.1% | 0.00% | 0.0% |
Q3 2018 | $279,000 | +92.4% | 13,380 | +99.0% | 0.00% | +100.0% |
Q2 2018 | $145,000 | 0.0% | 6,722 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $145,000 | -22.0% | 6,722 | +9.3% | 0.00% | -50.0% |
Q4 2017 | $186,000 | -24.7% | 6,149 | -5.5% | 0.00% | -33.3% |
Q3 2017 | $247,000 | +112.9% | 6,509 | +56.8% | 0.00% | +200.0% |
Q2 2017 | $116,000 | +31.8% | 4,151 | +62.1% | 0.00% | 0.0% |
Q1 2017 | $88,000 | +49.2% | 2,561 | +28.0% | 0.00% | 0.0% |
Q4 2016 | $59,000 | 0.0% | 2,000 | +6.6% | 0.00% | 0.0% |
Q3 2016 | $59,000 | +63.9% | 1,877 | +64.9% | 0.00% | 0.0% |
Q2 2016 | $36,000 | +33.3% | 1,138 | +15.1% | 0.00% | – |
Q1 2016 | $27,000 | -32.5% | 989 | -12.6% | 0.00% | -100.0% |
Q4 2015 | $40,000 | +5.3% | 1,131 | -2.7% | 0.00% | 0.0% |
Q3 2015 | $38,000 | -7.3% | 1,162 | +19.2% | 0.00% | 0.0% |
Q2 2015 | $41,000 | +241.7% | 975 | +156.6% | 0.00% | – |
Q1 2015 | $12,000 | +200.0% | 380 | +230.4% | 0.00% | – |
Q4 2014 | $4,000 | +33.3% | 115 | 0.0% | 0.00% | – |
Q3 2014 | $3,000 | 0.0% | 115 | 0.0% | 0.00% | – |
Q2 2014 | $3,000 | +200.0% | 115 | +360.0% | 0.00% | – |
Q1 2014 | $1,000 | -93.8% | 25 | -96.1% | 0.00% | – |
Q4 2013 | $16,000 | +1500.0% | 645 | +2480.0% | 0.00% | – |
Q3 2013 | $1,000 | – | 25 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |